Having revealed the expression profile of DCM’s targets (NQO1 and VKORC1) in AECs, we then explored whether the NQO1 and VKORC1 expressions in AECs correlated with the COVID-19 severity in clinical patients (Fig. 4a). This evidence concerns the gene NQO1 and familial dilated cardiomyopathy.